Let’s team up to stop GSOB and help keep Southern California’s oak woodlands healthy and thriving for wildlife, for people, and for future generations. Contact Questions or more information about the ...

Minerva has an FDA-approved IND for a MUC1*-CAR22 that persists longer in vivo enabling a more durable response in solid tumor treatment. We thank Memorial Sloan Kettering Cancer Center for the ...

We showed that in animal models, the MUC1* CAR-1XX increased CAR T-cell persistence and suppressed tumor recurrence by enabling the killing of low antigen-expressing cancer cells. "These findings ...

This post was updated May 18 at 10:03 p.m. California Gov. Gavin Newsom’s May 14 revision of the state budget reduced proposed funding cuts to the UC.

To the UC Davis community: UC Davis has a long history of innovation and an extraordinary community of students, faculty, staff and alumni who make it the great institution it is. Today, we must tap ...

Trump administration terminates $12M in grant funding for UC Davis research on sustainable transportation "As we navigate the complex landscape, we remain committed to maintaining and uplifting a ...

UC Berkeley’s Academic Senate, comprised of campus faculty, approved the resolution last week. The resolution was signed by nearly 50 faculty members from academic departments across Cal.

President Donald Trump's administration is launching an investigation into UC Berkeley's foreign funding, a week after it launched one into Harvard's records.

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer Institute Second Versamune® platform candidate targets MUC1-positive solid tumors U.S. Patent ...

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer Institute Second Versamune® platform candidate targets MUC1-positive solid tumors U.S. Patent ...